| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | pseudopodium | 1.37e-05 | 18 | 55 | 3 | GO:0031143 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 1.11e-04 | 290 | 55 | 6 | GO:0043292 | |
| GeneOntologyCellularComponent | sarcomere | 4.93e-04 | 249 | 55 | 5 | GO:0030017 | |
| GeneOntologyCellularComponent | Z disc | 6.70e-04 | 151 | 55 | 4 | GO:0030018 | |
| GeneOntologyCellularComponent | myofibril | 7.47e-04 | 273 | 55 | 5 | GO:0030016 | |
| GeneOntologyCellularComponent | I band | 9.54e-04 | 166 | 55 | 4 | GO:0031674 | |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 1.13e-03 | 19 | 55 | 2 | GO:0098871 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 1.89e-03 | 93 | 55 | 3 | GO:0030864 | |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 2.12e-03 | 26 | 55 | 2 | GO:0099571 | |
| GeneOntologyCellularComponent | striated muscle thin filament | 2.29e-03 | 27 | 55 | 2 | GO:0005865 | |
| Domain | EF-hand_Ca_insen | 5.07e-07 | 6 | 56 | 3 | IPR014837 | |
| Domain | EFhand_Ca_insen | 5.07e-07 | 6 | 56 | 3 | PF08726 | |
| Domain | CH | 4.28e-05 | 65 | 56 | 4 | SM00033 | |
| Domain | Actinin_actin-bd_CS | 4.33e-05 | 23 | 56 | 3 | IPR001589 | |
| Domain | Spectrin | 4.33e-05 | 23 | 56 | 3 | PF00435 | |
| Domain | ACTININ_2 | 4.33e-05 | 23 | 56 | 3 | PS00020 | |
| Domain | ACTININ_1 | 4.33e-05 | 23 | 56 | 3 | PS00019 | |
| Domain | CH | 5.74e-05 | 70 | 56 | 4 | PF00307 | |
| Domain | - | 6.07e-05 | 71 | 56 | 4 | 1.10.418.10 | |
| Domain | CH | 6.76e-05 | 73 | 56 | 4 | PS50021 | |
| Domain | CH-domain | 7.52e-05 | 75 | 56 | 4 | IPR001715 | |
| Domain | Spectrin_repeat | 8.83e-05 | 29 | 56 | 3 | IPR002017 | |
| Domain | Spectrin/alpha-actinin | 1.19e-04 | 32 | 56 | 3 | IPR018159 | |
| Domain | SPEC | 1.19e-04 | 32 | 56 | 3 | SM00150 | |
| Domain | IBN_N | 1.03e-03 | 16 | 56 | 2 | SM00913 | |
| Domain | EF-hand_1 | 1.11e-03 | 152 | 56 | 4 | PF00036 | |
| Domain | Importin-beta_N | 1.17e-03 | 17 | 56 | 2 | IPR001494 | |
| Domain | EFh | 1.29e-03 | 158 | 56 | 4 | SM00054 | |
| Domain | EGF_CA | 2.19e-03 | 86 | 56 | 3 | PF07645 | |
| Domain | EGF_Ca-bd_CS | 3.08e-03 | 97 | 56 | 3 | IPR018097 | |
| Domain | EGF_CA | 3.27e-03 | 99 | 56 | 3 | PS01187 | |
| Domain | ASX_HYDROXYL | 3.36e-03 | 100 | 56 | 3 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.96e-03 | 106 | 56 | 3 | IPR000152 | |
| Domain | EF_HAND_2 | 5.06e-03 | 231 | 56 | 4 | PS50222 | |
| Domain | EF_hand_dom | 5.14e-03 | 232 | 56 | 4 | IPR002048 | |
| Domain | EGF_CA | 5.86e-03 | 122 | 56 | 3 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 6.13e-03 | 124 | 56 | 3 | IPR001881 | |
| Domain | - | 6.40e-03 | 40 | 56 | 2 | 4.10.1000.10 | |
| Domain | - | 7.75e-03 | 261 | 56 | 4 | 1.10.238.10 | |
| Domain | ubiquitin | 8.75e-03 | 47 | 56 | 2 | PF00240 | |
| Pathway | REACTOME_NEPHRIN_FAMILY_INTERACTIONS | 3.60e-05 | 23 | 40 | 3 | M913 | |
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 10656685 | ||
| Pubmed | 3.95e-09 | 3 | 56 | 3 | 8104223 | ||
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 1629252 | ||
| Pubmed | 1.58e-08 | 4 | 56 | 3 | 16807302 | ||
| Pubmed | Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner. | 3.94e-08 | 5 | 56 | 3 | 15841212 | |
| Pubmed | The adenosine A2A receptor interacts with the actin-binding protein alpha-actinin. | 3.94e-08 | 5 | 56 | 3 | 12837758 | |
| Pubmed | 3.94e-08 | 5 | 56 | 3 | 19943616 | ||
| Pubmed | 7.88e-08 | 6 | 56 | 3 | 18425115 | ||
| Pubmed | 7.88e-08 | 6 | 56 | 3 | 22693585 | ||
| Pubmed | Mice deficient in alpha-actinin-4 have severe glomerular disease. | 2.20e-07 | 8 | 56 | 3 | 12782671 | |
| Pubmed | CHAP is a newly identified Z-disc protein essential for heart and skeletal muscle function. | 2.20e-07 | 8 | 56 | 3 | 20215401 | |
| Pubmed | Tropomodulin isoforms regulate thin filament pointed-end capping and skeletal muscle physiology. | 4.71e-07 | 10 | 56 | 3 | 20368620 | |
| Pubmed | Phosphorylation of mouse LASP-1 on threonine 156 by cAMP- and cGMP-dependent protein kinase. | 8.61e-07 | 12 | 56 | 3 | 15465019 | |
| Pubmed | 1.77e-06 | 15 | 56 | 3 | 11440986 | ||
| Pubmed | ADAMTS12 STARD13 AHCYL1 SACS CEBPZ ACTN4 LIMCH1 ACTN2 ACTN3 PFKM SLC4A3 CUX1 | 2.53e-06 | 1442 | 56 | 12 | 35575683 | |
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 9675099 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 12891711 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 19150855 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 25518808 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 22253474 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 19696509 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 32451822 | ||
| Pubmed | 2.55e-06 | 2 | 56 | 2 | 1339456 | ||
| Pubmed | TTLL12 NDST1 AHCYL1 SACS KIF1B ACTN4 CABIN1 TUBGCP5 CFAP298 SLC4A3 CUX1 | 5.42e-06 | 1285 | 56 | 11 | 35914814 | |
| Pubmed | α-Actinin-3 deficiency is associated with reduced bone mass in human and mouse. | 7.63e-06 | 3 | 56 | 2 | 21784188 | |
| Pubmed | Colocalization of α-actinin and synaptopodin in the pyramidal cell axon initial segment. | 7.63e-06 | 3 | 56 | 2 | 21940706 | |
| Pubmed | Insights into the Role of a Cardiomyopathy-Causing Genetic Variant in ACTN2. | 1.13e-05 | 27 | 56 | 3 | 36899856 | |
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 29561261 | ||
| Pubmed | 1.52e-05 | 4 | 56 | 2 | 16510730 | ||
| Pubmed | Evolution of Human Brain Size-Associated NOTCH2NL Genes Proceeds toward Reduced Protein Levels. | 1.52e-05 | 4 | 56 | 2 | 32330268 | |
| Pubmed | Human-Specific NOTCH2NL Genes Affect Notch Signaling and Cortical Neurogenesis. | 2.54e-05 | 5 | 56 | 2 | 29856954 | |
| Pubmed | Human-Specific NOTCH2NL Genes Expand Cortical Neurogenesis through Delta/Notch Regulation. | 2.54e-05 | 5 | 56 | 2 | 29856955 | |
| Pubmed | 2.54e-05 | 5 | 56 | 2 | 9268580 | ||
| Pubmed | 2.54e-05 | 5 | 56 | 2 | 21536590 | ||
| Pubmed | p27Kip1 is expressed transiently in developing myotomes and enhances myogenesis. | 2.54e-05 | 5 | 56 | 2 | 9438383 | |
| Pubmed | Myozenin: an alpha-actinin- and gamma-filamin-binding protein of skeletal muscle Z lines. | 2.54e-05 | 5 | 56 | 2 | 11171996 | |
| Pubmed | 3.80e-05 | 6 | 56 | 2 | 17438131 | ||
| Pubmed | 5.32e-05 | 7 | 56 | 2 | 18981215 | ||
| Pubmed | 5.32e-05 | 7 | 56 | 2 | 11724819 | ||
| Pubmed | Gene defect in ectodermal dysplasia implicates a death domain adapter in development. | 5.32e-05 | 7 | 56 | 2 | 11780064 | |
| Pubmed | 7.09e-05 | 8 | 56 | 2 | 32878913 | ||
| Pubmed | 7.09e-05 | 8 | 56 | 2 | 11309420 | ||
| Pubmed | 7.09e-05 | 8 | 56 | 2 | 11381084 | ||
| Pubmed | 7.09e-05 | 8 | 56 | 2 | 18687124 | ||
| Pubmed | 7.09e-05 | 8 | 56 | 2 | 14565974 | ||
| Pubmed | 8.32e-05 | 653 | 56 | 7 | 22586326 | ||
| Pubmed | 8.98e-05 | 1440 | 56 | 10 | 30833792 | ||
| Pubmed | Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. | 9.10e-05 | 9 | 56 | 2 | 11114196 | |
| Pubmed | GWAS of longevity in CHARGE consortium confirms APOE and FOXO3 candidacy. | 1.14e-04 | 10 | 56 | 2 | 25199915 | |
| Pubmed | 1.39e-04 | 11 | 56 | 2 | 27680501 | ||
| Pubmed | 1.39e-04 | 11 | 56 | 2 | 16769906 | ||
| Pubmed | 1.39e-04 | 11 | 56 | 2 | 16585392 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | 1.51e-04 | 719 | 56 | 7 | 35337019 | |
| Pubmed | 1.66e-04 | 170 | 56 | 4 | 15057823 | ||
| Pubmed | Molecular diversity of myofibrillar proteins: gene regulation and functional significance. | 1.66e-04 | 12 | 56 | 2 | 8618961 | |
| Pubmed | Pocket proteins pRb and p107 are required for cortical lamination independent of apoptosis. | 1.66e-04 | 12 | 56 | 2 | 24056077 | |
| Pubmed | Systematic screening for skin, hair, and nail abnormalities in a large-scale knockout mouse program. | 1.70e-04 | 171 | 56 | 4 | 28700664 | |
| Pubmed | 1.96e-04 | 13 | 56 | 2 | 14697242 | ||
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.97e-04 | 332 | 56 | 5 | 32786267 | |
| Pubmed | 2.29e-04 | 14 | 56 | 2 | 36706168 | ||
| Pubmed | 2.39e-04 | 187 | 56 | 4 | 26460568 | ||
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 2.83e-04 | 1061 | 56 | 8 | 33845483 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | 2.89e-04 | 1353 | 56 | 9 | 29467282 | |
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | 3.15e-04 | 573 | 56 | 6 | 28330616 | |
| Pubmed | 3.41e-04 | 17 | 56 | 2 | 34184027 | ||
| Pubmed | Nova2 regulates neuronal migration through an RNA switch in disabled-1 signaling. | 3.41e-04 | 17 | 56 | 2 | 20620871 | |
| Pubmed | ASPM regulates symmetric stem cell division by tuning Cyclin E ubiquitination. | 3.41e-04 | 17 | 56 | 2 | 26581405 | |
| Pubmed | 4.28e-04 | 19 | 56 | 2 | 26113728 | ||
| Pubmed | 4.28e-04 | 19 | 56 | 2 | 29618652 | ||
| Pubmed | Transcriptional fates of human-specific segmental duplications in brain. | 4.28e-04 | 19 | 56 | 2 | 30228200 | |
| Pubmed | 4.31e-04 | 608 | 56 | 6 | 16713569 | ||
| Pubmed | 4.36e-04 | 1431 | 56 | 9 | 37142655 | ||
| Pubmed | Early dorsomedial tissue interactions regulate gyrification of distal neocortex. | 5.24e-04 | 21 | 56 | 2 | 31729356 | |
| Pubmed | 7.14e-04 | 250 | 56 | 4 | 33536335 | ||
| Pubmed | SOCS2 Binds to and Regulates EphA2 through Multiple Mechanisms. | 7.55e-04 | 110 | 56 | 3 | 28883622 | |
| Pubmed | Rack1 is essential for corticogenesis by preventing p21-dependent senescence in neural stem cells. | 8.07e-04 | 26 | 56 | 2 | 34469723 | |
| Pubmed | 8.23e-04 | 1247 | 56 | 8 | 27684187 | ||
| Pubmed | Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer. | 8.74e-04 | 264 | 56 | 4 | 32814769 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 9.28e-04 | 974 | 56 | 7 | 28675297 | |
| Pubmed | 9.37e-04 | 28 | 56 | 2 | 30947518 | ||
| Pubmed | A Genome-Wide CRISPR Screen Identifies Genes Critical for Resistance to FLT3 Inhibitor AC220. | 9.49e-04 | 119 | 56 | 3 | 28625976 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 1.02e-03 | 477 | 56 | 5 | 31300519 | |
| Pubmed | 1.08e-03 | 30 | 56 | 2 | 24472646 | ||
| Pubmed | A genome-wide association study of behavioral disinhibition. | 1.08e-03 | 30 | 56 | 2 | 23942779 | |
| Pubmed | A function for cyclin D1 in DNA repair uncovered by protein interactome analyses in human cancers. | 1.09e-03 | 125 | 56 | 3 | 21654808 | |
| Pubmed | 1.10e-03 | 281 | 56 | 4 | 24163370 | ||
| Pubmed | Vti1b promotes TRPV1 sensitization during inflammatory pain. | 1.14e-03 | 127 | 56 | 3 | 30335684 | |
| Pubmed | STK11 is required for the normal program of ciliated cell differentiation in airways. | 1.15e-03 | 31 | 56 | 2 | 31636950 | |
| Pubmed | 1.15e-03 | 31 | 56 | 2 | 14630798 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 1.16e-03 | 736 | 56 | 6 | 29676528 | |
| Pubmed | Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. | 1.21e-03 | 742 | 56 | 6 | 26871637 | |
| Pubmed | HMGB1 interacts with many apparently unrelated proteins by recognizing short amino acid sequences. | 1.22e-03 | 32 | 56 | 2 | 11748221 | |
| Pubmed | 1.22e-03 | 497 | 56 | 5 | 23414517 | ||
| Pubmed | 1.30e-03 | 33 | 56 | 2 | 19817957 | ||
| Pubmed | 1.30e-03 | 33 | 56 | 2 | 29950483 | ||
| Interaction | MYOZ2 interactions | 3.50e-07 | 22 | 55 | 4 | int:MYOZ2 | |
| GeneFamily | Actinins | 2.21e-08 | 4 | 33 | 3 | 1112 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-06 | 182 | 56 | 5 | dbe4b2557cf19e0682ed446f8397d3a1153642f0 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.31e-06 | 182 | 56 | 5 | c557de6ccd327c46e0a5423cd9936d78e0abae5f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.52e-06 | 194 | 56 | 5 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | severe_COVID-19-pDC|World / disease group, cell group and cell class (v2) | 4.78e-05 | 159 | 56 | 4 | e1c48c4ceda116826819ff9adeed7bad6a58844d | |
| ToppCell | severe_COVID-19-pDC|severe_COVID-19 / disease group, cell group and cell class (v2) | 4.78e-05 | 159 | 56 | 4 | ea5088d27e42b8850455764d53b757ea8d8f14bc | |
| ToppCell | facs-Lung-nan-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-05 | 170 | 56 | 4 | 67d7e1da3ebd2d14cb2e67799e94d655027ed5c4 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.20e-05 | 170 | 56 | 4 | 8e1f757ed62218c0fb6525f49d142dd2cd29acf9 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.74e-05 | 180 | 56 | 4 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.74e-05 | 180 | 56 | 4 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-migDC|lymph-node_spleen / Manually curated celltypes from each tissue | 7.90e-05 | 181 | 56 | 4 | 94680f8dbdf22d83801abc0819417751d363fb12 | |
| ToppCell | E18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 8.07e-05 | 182 | 56 | 4 | ceb37c214662a48efb56ab0d015977c6fab478b0 | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 184 | 56 | 4 | 89ac32e374a4379e4a6c6ea7603b1378b77c147f | |
| ToppCell | droplet-Lung-nan-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.42e-05 | 184 | 56 | 4 | 4df6027fa635996c1eddb920f88a5265772df1cd | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 8.96e-05 | 187 | 56 | 4 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | PND07-28-samps-Mesenchymal-Matrix_fibroblast-FB-3|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 9.53e-05 | 190 | 56 | 4 | 1196b8ea2c44c7c80f5ee589dd517e6a413f2077 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 9.73e-05 | 191 | 56 | 4 | 3379d145d34f89150f7b06d1340022cfc6b4a6ce | |
| ToppCell | PND01-03-samps-Mesenchymal-Matrix_fibroblast-MatrixFB-A|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 9.73e-05 | 191 | 56 | 4 | e7c605b56934d1383237c1f946dbccef25d91368 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.73e-05 | 191 | 56 | 4 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 193 | 56 | 4 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.01e-04 | 193 | 56 | 4 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.01e-04 | 193 | 56 | 4 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.01e-04 | 193 | 56 | 4 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-04 | 194 | 56 | 4 | ad3eb98f94a007c5988ede06238255f5b03bee6e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.03e-04 | 194 | 56 | 4 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-04 | 194 | 56 | 4 | a281ebab117589fc922ead0a712cfe0a844c94ac | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 1.05e-04 | 195 | 56 | 4 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-04 | 195 | 56 | 4 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-04 | 196 | 56 | 4 | 9790340c25f446ec655f5a0b64ec3bb44ed2e1bd | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-04 | 196 | 56 | 4 | b9ceceeacbcf81976ce92adf044f0d0aa132632b | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-04 | 196 | 56 | 4 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.10e-04 | 197 | 56 | 4 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | (5)_Dendritic_cell-(53)_Lymphoid_DC|(5)_Dendritic_cell / shred on Cell_type and subtype | 1.12e-04 | 198 | 56 | 4 | 548da5fa86f9756c503ed77bcdde55bc4d1a2726 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.12e-04 | 198 | 56 | 4 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.14e-04 | 199 | 56 | 4 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.14e-04 | 199 | 56 | 4 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 200 | 56 | 4 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.16e-04 | 200 | 56 | 4 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.16e-04 | 200 | 56 | 4 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-04 | 200 | 56 | 4 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| Drug | Acetohexamide [968-81-0]; Up 200; 12.4uM; HL60; HT_HG-U133A | 3.82e-07 | 195 | 54 | 7 | 1870_UP | |
| Drug | Adrenosterone [382-45-6]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 7.53e-06 | 199 | 54 | 6 | 5464_DN | |
| Disease | focal segmental glomerulosclerosis 1 (implicated_via_orthology) | 5.78e-08 | 5 | 54 | 3 | DOID:0111128 (implicated_via_orthology) | |
| Disease | platelet measurement | 2.77e-04 | 315 | 54 | 5 | EFO_0005036 | |
| Disease | immature platelet fraction | 1.21e-03 | 114 | 54 | 3 | EFO_0009187 | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 1.38e-03 | 30 | 54 | 2 | C1868672 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LRWHQDWQKEPRKYE | 506 | Q6UWY0 | |
| RDWLTQDWLHPLMDK | 536 | Q17RC7 | |
| DRSQEPHWRETARWI | 331 | P48751 | |
| PHWRETARWIKFEED | 336 | P48751 | |
| WDRDLLLDPAWEKQQ | 26 | P35609 | |
| KDHWWSAVQPERRNA | 821 | P39880 | |
| DDWDRDLLLDPAWEK | 36 | O43707 | |
| KPWLFTEIKEQRHWD | 526 | Q96G46 | |
| KAWRRAQWHEQILVP | 231 | Q8N5I2 | |
| ELWREKWERHNLPSR | 221 | P58397 | |
| GDILRIRDKPEEQWW | 156 | P46108 | |
| ENDDARKLWWLPAHL | 521 | Q9ULI1 | |
| IPDHVRERAWLTWEK | 66 | P06400 | |
| WERDREVWNGKEHDE | 221 | Q7Z3S9 | |
| IRRKFWPEWHHDDDN | 326 | Q5TGI0 | |
| WIREKDNDLHWEPIR | 431 | Q6UXI9 | |
| WRPRGDSLILEHQWE | 1481 | O60333 | |
| QLWCHKRWEEKEERL | 301 | Q6UWP7 | |
| DEQTLHRAREWDDWK | 311 | P78318 | |
| HRAREWDDWKDTHPR | 316 | P78318 | |
| DFEHRIPKEQWWLKL | 731 | P08237 | |
| LWQDPCEDKRHKDIW | 581 | P52848 | |
| WKDEPDDRSWLEHHV | 206 | Q96RT8 | |
| WERDREVWNGKEHDE | 221 | P0DPK4 | |
| QWLQPHREWKEEVLD | 21 | Q15646 | |
| DVNNWWIVKDPRRHQ | 371 | Q9Y6A1 | |
| WKVLVPEHEKDVLEW | 326 | P48147 | |
| EAEAQLWWAAKELRR | 186 | P57076 | |
| LPWIILHRIIWQEED | 846 | Q9Y6J0 | |
| NWIKDADPRVEDWLL | 16 | A1L3X0 | |
| ESWLWEVHLVPRRKQ | 771 | P01031 | |
| VEKVLRRWVDEEWPK | 191 | Q8WWZ3 | |
| DDLRVIVWDWVRQKP | 216 | A6NGE4 | |
| EVLDDSRKWWKVRDP | 506 | Q8TE68 | |
| WDPVKVHDIRWNFEK | 171 | O75715 | |
| HRAPSEEEALEKWDW | 16 | Q14147 | |
| SIKWRELDQWRDPAA | 476 | Q9NZJ4 | |
| KQLRWEAERDDWLHN | 1011 | Q03701 | |
| WAWDPEEERRRQEKW | 766 | Q9UPQ0 | |
| HEWEQIIDILWSDPR | 351 | O14829 | |
| LHIDEDDRPELVWWK | 246 | O15397 | |
| IRWLRVHAPEVDWIK | 506 | A6NKG5 | |
| LRERHLWDEDFVQWK | 971 | Q9Y3M8 | |
| ENWPSEEEIRRFWKL | 251 | Q9C0I9 | |
| WERVRSQVDHVIWPD | 416 | O43865 | |
| EQWHPLREWLGRLEA | 51 | Q6ZWJ8 | |
| LEEWLPRELWHEING | 266 | P78549 | |
| PDRRATIEDIANHWW | 291 | O60285 | |
| LRHPSGWWLVENEDR | 196 | Q8NFA2 | |
| RVWRWPDLQSHHELK | 91 | Q99717 | |
| EDWDRDLLLDPAWEK | 31 | Q08043 | |
| RLAWGRDENEKIWDE | 26 | Q9P291 | |
| PRHKDAWRQPEDTWA | 706 | Q63HN8 | |
| WKPHKWVDVRLALEQ | 621 | Q7Z6L1 | |
| REWPQHWPDMLIELD | 126 | Q9HAV4 | |
| LEPVLDRDRWSWDRH | 521 | Q6ZUG5 | |
| QRERWGEDNHWICKP | 406 | Q14166 | |
| DGEEQRPRKAWAWRL | 476 | P51687 | |
| REWDRDADKDWPRNR | 1321 | Q5T200 |